Drug Database
N07BC01 buprenorphine
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Buprenorphine 2 mg sublingual tablets
- POM Buprenorphine 2 mg sublingual tablets
- POM Buprenorphine 8 mg sublingual tablets
- POM Buprenorphine 8 mg sublingual tablets
- POM Buvidal 128 mg prolonged-release solution for injection
- POM Buvidal 16 mg prolonged-release solution for injection
- POM Buvidal 160 mg prolonged-release solution for injection
- POM Buvidal 24 mg prolonged-release solution for injection
- POM Buvidal 32 mg prolonged-release solution for injection
- POM Buvidal 64/96/128 mg prolonged-release solution for injection
- POM Buvidal 8/16/24/32 mg prolonged-release solution for injection
- POM Buvidal 96 mg prolonged-release solution for injection
- POM Espranor 2 mg oral lyophilisate
- POM Espranor 8 mg oral lyophilisate
- POM Prefibin 2 mg Sublingual Tablets
- POM Prefibin 8 mg Sublingual Tablets
- POM Sixmo 74.2 mg implant ▼
- POM Subutex 0.4, 2mg and 8mg sublingual tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).